XML 16 R9.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Accounts Receivable | 3 Months Ended
--- | ---
Mar. 31, 2024
Receivables [Abstract] |
Accounts Receivable | 3. Accounts Receivable Accounts receivable, net consists of the following (in thousands):
|  | March 31, 2024 |  |  | December 31, 2023 |
Accounts receivable – commercial |  |  |  |  |  |
Accounts receivable, gross |  | $ | 17,516 |  |  | $ | 20,199 |
Wholesaler distribution fees and prompt pay discounts |  |  | (2,252 | ) |  |  | (2,469 | )
Reserve for returns |  |  | (5,597 | ) |  |  | (6,215 | )
Allowance for credit losses |  |  | (157 | ) |  |  | (157 | )
Total accounts receivable – commercial, net |  |  | 9,510 |  |  |  | 11,358 |
Accounts receivable – collaborations and services |  |  | 10,402 |  |  |  | 3,543 |
Total accounts receivable, net |  | $ | 19,912 |  |  | $ | 14,901 |
As of March 31, 2024 and December 31, 2023, the allowance for credit losses and doubtful accounts for commercial accounts receivable of $0.2 million was related to $0.2 million of accounts receivable for Zealand Pharma US, Inc. As of March 31, 2024, the Company had three wholesale distributors representing approximately 78% of commercial accounts receivable and 70% of gross sales during the three months ended March 31, 2024. As of March 31, 2024 and December 31, 2023, there was no allowance for credit losses for accounts receivable for collaborations and services. The Company had one collaboration partner, UT, that comprised 100% of the collaboration and services net accounts receivable as of March 31, 2024 and December 31, 2023 and approximately 100% of gross revenue from collaborations and services for the three months ended March 31, 2024 and 2023.

X
- Definition The entire disclosure for financing receivable. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481962/310-10-50-42 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 12A -Publisher FASB -URI https://asc.fasb.org//1943274/2147481933/310-10-55-12A Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 44 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481962/310-10-50-44 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//310-10/tableOfContent Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//310-20/tableOfContent + Details
Name: | us-gaap_FinancingReceivablesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ReceivablesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration